Ranbaxy Laboratories gets US FDA nod for Plendil generic: Report

18 Dec 2013 Evaluate

Ranbaxy Laboratories has reportedly received US Food and Drug Administration (US FDA) approval for a particular drug called Plendil generic. The drug is used for hypertension. The company was expected to be the authorised generic for this particular drug, but it is already genericised and there are already 6-7 players in this market for this particular drug.

For Ranbaxy this is the first approval that they have received from the USFDA after two years, after the Lipitor generic received approval.

Ranbaxy Laboratories, India’s largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

 

Peers
Company Name CMP
Sun Pharma Inds. 1645.25
Dr. Reddys Lab 1187.85
Cipla 1388.50
Zydus Lifesciences 879.05
Lupin 2164.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×